I see a lot of people overlooking US cannabis these days so I just wanted to quickly set the record straight on the outlook of the industry in 2021. In just this year alone, we are looking towards several key major catalysts such as:
- the SAFE act for MSOs to get access to banking
- uplisting to NYSE (US MSOs are currently traded as OTC leaving the vast majority of institutional investors on the outside looking in for now)
- more states legalizing independently
Decriminalization even without full legalization would be a major boon for growth but is not even necessary for growth to continue with more states legalizing and/or relaxing restrictions on MSOs. The 4 major players (Green Thumb, Cresco, Trulieve, and Curaleaf) are all on top in this. They maintained solid financials, limited debt/losses, huge expansion across all medical/recreational states and are almost certainly going to remain the big 4 post-legalization. A play across these 4 covers the majority of gains we'll see leading up to and after legalization.
So we know who to invest in, what to look out for and when to expect it. We're past speculation for the cannabis market at this point. The industry is matured and ready to go big in 2021.
Submitted February 23, 2021 at 11:00PM by TheCommonKoala https://ift.tt/2NymIlI
